
Careers
What if you joined the team?
Joining Kereval means joining a family and human SME that contributes to a work of excellence on technical and exciting projects in various sectors of activity!
Beyond your skills, we will pay particular attention to your personality! To join Kereval is to live its values where conviviality, culture of exchange and teamwork reign.
We are committed to investing in the professional support of our employees, so that everyone can continue to develop their skills.
A year at Kereval is naturally punctuated by convivial moments at the initiative of all! The Kereval spirit is based on the desire to work together and our collective success!

Bug tracker
At Kereval, the tester participates in the test campaigns by executing the different test scenarios and by ensuring a reliable reporting with a good restitution on the encountered problems.
Depending on his experience and skills, the tester evolves towards the job of test analyst who will design the test scenarios from the analysis of the specifications and the test strategy.
The test analyst can evolve towards a job as a test automatician if he wishes to invest in technical issues.
They may also move into a consulting role to manage the development of test plans and define test strategy or participate in consulting assignments such as test process audits.
There are also opportunities to move into management positions.

Either Full Stack
It is around our test benches that the software development evolves at Kereval.
The development and test engineer is at the heart of the developments. He ensures the developments and the daily maintenance of the bench.
The experienced engineer can, if he wishes, invest in studies by evolving as an architect. This is to propose the most optimal architecture and technologies around which to build and develop the test bench.
It is also possible to evolve in a support role as a technical referent or tech lead. The technical skills acquired allow you to assist the architect in his studies and the project manager with the customers.
Translated with www.DeepL.com/Translator (free version)

Either intrusive
Our cybersecurity consultants take charge of pentests and audits of intrusion, architecture or configuration.
Our goal is to combine the cybersecurity skills of our consultants with skills from a business world. This allows our cybersecurity consultants to take a step back in the analysis of their audit results and to make more relevant proposals to our customers.
For example, our current investment focus is on vehicle cybersecurity thanks to our BUS / CAN business.

The heart of the systems
L’expertise de Kereval en interopérabilité des systèmes d’information de santé est portée par nos consultants e-santé. Plusieurs profils-types se dégagent.
- Des experts dans les normes d’interopérabilité HL7 V2/V3, CDA, FHIR pouvant intervenir en conseil sur l’élaboration de cadres d’interopérabilité internationaux ou nationaux.
- Des profils fonctionnels pour spécifier fonctionnellement de nouveaux cas d’usage et les échanges entre systèmes.
- Des profils techniques pour spécifier techniquement les échanges entre les cas d’usage.
Latest articles
Kereval CEO Re-elected Co-President of IHE-France
9 April 2026
The Interop’Santé / IHE-France association, which works to harmonize and promote the exchange of health information in France, announced on March 30 the re-election of the two co-presidents of IHE-France and the president of HL7 France. Abdelmoula Tamoudi, CEO of Kereval and a member of IHE-Europe, was re-elected co-chair of IHE-France to represent digital health … Kereval CEO Re-elected Co-President of IHE-France
New European project dedicated to digital twins of territories
26 February 2026
Kereval is participating in the European project LDT4SSC Project (Local Digital Twin for Smart & Sustainable Communities), funded by the European Commission, dedicated to the development of a shared and scalable European network of local digital twins. Territorial digital twins function as true virtual representations of territories. They make it possible to simulate different scenarios … New European project dedicated to digital twins of territories
Kereval Evaluates the Fairness of AI Models in Oncology
24 February 2026
Kereval is one of 17 successful applicants to a call for expressions of interest issued by the Health Data Hub (HDH), which is implementing the government’s strategy for the National Health Data System (SNDS). The project led by Kereval, known as Santé2Fair, aims to develop a methodological framework for assessing the fairness of artificial intelligence (AI) … Kereval Evaluates the Fairness of AI Models in Oncology
Connectathon IHE Europe: a week dedicated to healthcare interoperability
9 February 2026
The IHE-Europe Connectathon 2026, a major event in digital health, will take place from March 23 to 27, 2026, in Brussels, Belgium. Organized by IHE-Europe (Integrating the Healthcare Enterprise), this international event brings together stakeholders from across the ecosystem each year to test and validate the interoperability of digital health solutions according to recognized standards. … Connectathon IHE Europe: a week dedicated to healthcare interoperability
Kereval partners with a new project to improve the predictability of industrial obsolescence
12 January 2026
Kereval is involved in a new collaborative innovation project called PrediObso, which aims to transform the maintenance of complex equipment in operational condition (MOC) in order to reduce obsolescence. This project, led by OBSAM (OBSolescence and Analysis Management), brings its business expertise and unique Ostral database, the first collaborative multi-domain and multi-family database in France. … Kereval partners with a new project to improve the predictability of industrial obsolescence
Partnering with AP-HP to Better Target Patients for Clinical Trials
8 January 2026
Healthcare Kereval is involved in a new research project called PénélopAlgo, which aims to facilitate the use of health data to improve patient targeting for clinical trials. The project addresses the challenge of low patient recruitment rates in clinical studies—which can hinder the validation of new therapies—as well as the limited access to clinical trials as … Partnering with AP-HP to Better Target Patients for Clinical Trials
